These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9116317)

  • 1. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size.
    Jain M; Miller AB
    Breast Cancer Res Treat; 1997 Jan; 42(1):43-55. PubMed ID: 9116317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premorbid diet and the prognosis of women with breast cancer.
    Jain M; Miller AB; To T
    J Natl Cancer Inst; 1994 Sep; 86(18):1390-7. PubMed ID: 8072032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
    Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
    Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fat and risk of breast cancer according to hormone receptor status.
    Kushi LH; Potter JD; Bostick RM; Drinkard CR; Sellers TA; Gapstur SM; Cerhan JR; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):11-9. PubMed ID: 7894319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
    Zhang M; Yang H; Holman CD
    Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A
    Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
    Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional factors, physical activity, and breast cancer by hormonal receptor status.
    Rosato V; Bertuccio P; Bosetti C; Negri E; Edefonti V; Ferraroni M; Decarli A; Talamini R; Dal Maso L; Falcini F; Montella M; Franceschi S; La Vecchia C
    Breast; 2013 Oct; 22(5):887-93. PubMed ID: 23643804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmö Diet and Cancer cohort.
    Wirfält E; Li C; Manjer J; Ericson U; Sonestedt E; Borgquist S; Landberg G; Olsson H; Gullberg B
    Nutr Cancer; 2011; 63(5):722-33. PubMed ID: 21767080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer.
    Gilbert L; Elwood LJ; Merino M; Masood S; Barnes R; Steinberg SM; Lazarous DF; Pierce L; d'Angelo T; Moscow JA
    J Clin Oncol; 1993 Jan; 11(1):49-58. PubMed ID: 8418241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for breast cancer according to estrogen and progesterone receptor status.
    Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
    J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.